An integrated microbiome and metabolomic analysis identifies immunoenhancing features of Ganoderma lucidum spores oil in mice
Xu Wu,Jiliang Cao,Mingxing Li,Peifen Yao,Hongyi Li,Wendong Xu,Cheng Yuan,Juyan Liu,Shengpeng Wang,Peng Li,Yitao Wang
DOI: https://doi.org/10.1016/j.phrs.2020.104937
IF: 10.334
2020-08-01
Pharmacological Research
Abstract:<p><em>Ganoderma lucidum</em> (Leyss. ex Fr.) Karst. is a valuable dietary supplement used worldwide for promoting health as well as a medicinal fungus for handling fatigue, immunological disorders, and cancer. Previous studies have revealed the immunoenhancing effect of <em>G. lucidum</em> and the polysaccharide extract, with potential involvement of gut microbiome. The spore oil of <em>G. lucidum</em> (GLSO), the lipid fraction, is one of the <em>G. lucidum</em>-related products, however, there is little evidence for immune promotion activity and the underlying mechanisms. The present study aims to investigate the immunoenhancing effect of GLSO in mice. GLSO (at 800 mg/kg) enhanced macrophage phagocytosis and NK cell cytotoxicity of mice. Further microbiome and metabolomics studies showed that GLSO induced structural rearrangement of gut microbiota, mediating alterations in a wide range of metabolites. By clustering, multivariate and correlation analysis, the immunoenhancing effect of GLSO was found to be highly correlated with elevated abundance of several bacterial genera (<em>Lactobacillus</em>, <em>Turicibacter</em> and <em>Romboutsia</em>) and species (<em>Lactobacillus_intestinalis</em> and <em>Lactobacillus_reuteri</em>), and decreased level of <em>Staphylococcus</em> and <em>Helicobacter</em>, which resulted in the regulation of a range of key metabolites such as dopamine, prolyl-glutamine, pentahomomethionine, leucyl-glutamine, L-threonine, stearoylcarnitine, dolichyl β-D-glucosyl phosphate, etc. These results provide new insights into the understanding of the modulatory effect of GLSO on immune system.</p>
pharmacology & pharmacy